Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence.

Cancers (Basel) · 2021 · PMC8036281 · PMID 33808149

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

on the borderline of significancep = 0.054so close (0.05 < p ≤ 0.1)

ECR rate was significantly higher in patients with clinically smaller tumors (OR = 2.7, p = 0.002), unifocal type (OR = 4.0, p = 0.035), and on the borderline of significance with Ki-67 proliferative index ≥65% (OR = 1.8, p = 0.054).

also in 75 other papers

did not reach statistical significanceno p-value reported

The type of NACT included in these analyses did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.